The Rheumatologist: November 2020

A Look Back at Pirquet & Schick’s Influential Serum Sickness Study

November 12, 2020 • By Ruth Jessen Hickman, MD

Mattew - Bilder und mehr / shutterstock.com

Yao Syndrome: A Case Report & Clinical Review

November 12, 2020 • By Peter Gorevic, MD, & Qingping Yao, MD, PhD

ACR President Ellen Gravallese, MD, Says Farewell

November 12, 2020 • By Ellen M. Gravallese, MD

The 2020 ACR Awards of Distinction & Masters Class

November 12, 2020 • By Linda Childers

Lessons from Master Clinicians: An Interview with Dr. Alan Baer

November 12, 2020 • By Jason Liebowitz, MD

Success & Challenges of Multidisciplinary Rheumatology Clinics

November 12, 2020 • By Julianna Desmarais, MD, & Marcia Friedman, MD

What’s the Role of Epstein-Barr Virus Reactivation in Lupus Development?

November 12, 2020 • By Larry Beresford

Studies Examine Peripheral Nervous System Disease in Lupus Patients

November 12, 2020 • By Linda Childers

Uveitis: A Brief Primer for the Rheumatologist

November 12, 2020 • By Meghan Berkenstock, MD

The Prescription for a Healthy Rheumatology Practice

November 12, 2020 • By Linda Childers

Study: Patient Global Assessment Scores Give Insight Into Daily Function

November 12, 2020 • By Ruth Jessen Hickman, MD

Rheumatologist in India Finds the Patient Global Assessment Challenging

November 12, 2020 • By Anand N. Malaviya, MD, FRCP, ACR Master

Study Looks at Cryoglobulin Detection & Immunological Characteristics

November 12, 2020 • By Vanessa Caceres

Study: DPP4 Inhibitors Yield Promise for Systemic Sclerosis Treatment

November 12, 2020 • By Ruth Jessen Hickman, MD

How to Terminate a Patient Relationship

November 12, 2020 • By Steven M. Harris, Esq.

Has the Mathematization of Rheumatoid Arthritis Gone Too Far?

November 12, 2020 • By Carlos Antonio Moura, MD, Ana Luísa Cerqueira de Sant’Ana Costa, MD, & Carlos Geraldo Moura, MD

Rheum After 5: Polly Ferguson, MD, Is Perfecting Her Pottery Skills

November 5, 2020 • By Carol Patton

FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis

October 21, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves Tofacitinib for Young Patients with Active Polyarticular JIA

October 9, 2020 • By Michele B. Kaufman, PharmD, BCGP

FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction

October 7, 2020 • By Michele B. Kaufman, PharmD, BCGP

View On-Demand Sessions & Content from ACR Convergence 2020

November 12, 2020 • By From the College

UHC Announces New Copay Accumulator Policy Affecting In-Office Treatments

October 6, 2020 • By From the College

The New Guidance Subcommittee Gives ACR More Document Flexibility

November 12, 2020 • By Ruth Jessen Hickman, MD

Advantages of Embedding a Specialty Pharmacist in a Rheumatology Clinic

November 12, 2020 • By Polly J. Ferguson, MD, Jessica Lynton, PharmD, BCPS, & Beth H. Resman-Targoff, PharmD, FCCP, on behalf of the ARP Membership & Nominations Committee

« Return to the Issue Archive

A Look Back at Pirquet & Schick’s Influential Serum Sickness Study

Yao Syndrome: A Case Report & Clinical Review

ACR President Ellen Gravallese, MD, Says Farewell

The 2020 ACR Awards of Distinction & Masters Class

Lessons from Master Clinicians: An Interview with Dr. Alan Baer

Success & Challenges of Multidisciplinary Rheumatology Clinics

What’s the Role of Epstein-Barr Virus Reactivation in Lupus Development?

Studies Examine Peripheral Nervous System Disease in Lupus Patients

Uveitis: A Brief Primer for the Rheumatologist

The Prescription for a Healthy Rheumatology Practice

Study: Patient Global Assessment Scores Give Insight Into Daily Function

Rheumatologist in India Finds the Patient Global Assessment Challenging

Study Looks at Cryoglobulin Detection & Immunological Characteristics

Study: DPP4 Inhibitors Yield Promise for Systemic Sclerosis Treatment

How to Terminate a Patient Relationship

Has the Mathematization of Rheumatoid Arthritis Gone Too Far?

Rheum After 5: Polly Ferguson, MD, Is Perfecting Her Pottery Skills

FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis

FDA Approves Tofacitinib for Young Patients with Active Polyarticular JIA

FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction

View On-Demand Sessions & Content from ACR Convergence 2020

UHC Announces New Copay Accumulator Policy Affecting In-Office Treatments

The New Guidance Subcommittee Gives ACR More Document Flexibility

Advantages of Embedding a Specialty Pharmacist in a Rheumatology Clinic

Simple Tasks

Meeting Abstracts

ACR Convergence